Presentations HIV Related Malignancies (Christopher Parsons, MD) Phase I Clinical Trials (Mark Matrana, MD) Molecular Diagnosis and Personalized Medicine – Cancer Management 2016 (William “Rusty” Robinson, III, MD) MACRA Update – Basics Getting Ready for the Post-SGR World (Sybil Green … Continued
University Medical Center – New Orleans (Click Here for the map to the conference center in the hospital from the parking garage on the corner of Tulane Ave and Galvez Street.) Agenda Registration Industry Meeting Registration
FDA modified the indication for erlotinib (TARCEVA, Astellas Pharm Global Development Inc.) for treatment of non-small cell lung cancer (NSCLC) to limit use to patients whose tumors have specific epidermal growth factor receptor (EGFR) mutations. October 18, 2016.
For healthcare providers, the MACRA rule was released today. It urges you to understand and learn how this will affect you because it will. Patients should also see how this will affect you because similar to Affordable Care, it will.